Affimed Therapeutics B.V. IPO Research Information

Affimed Therapeutics B.V. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Affimed Therapeutics B.V., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Affimed Therapeutics B.V.	AFMD - NASDAQ	$11.00-$13.00	$7.00	$6.95	8 million	9/12/2014
Underwriter(s): Jefferies, Leerink Partners BMO Capital Markets
Co-Manager(s): Trout Capital
Industry: Health Care
Filing(s): Filed 2014-06-27 Terms Added 2014-09-02

Affimed Therapeutics B.V. Quote & Chart - Click for current quote - AFMD

About Affimed Therapeutics B.V. (adapted from Affimed Therapeutics B.V. prospectus):
They are a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "AFMD" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.